Zhengye Biotechnology Holding annual gross margin
2024
2025
Zhengye Biotechnology Holding's gross margin was 20.51% for fiscal 2025.
View full Zhengye Biotechnology Holding company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 20.51% | −28.49 pp |
| 2024 | 2024-12-31 | 48.99% | — |
Between the periods ended 2024-12-31 and 2025-12-31, Zhengye Biotechnology Holding's gross margin decreased from 48.99% to 20.51%, a change of −28.49 percentage points.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Zhengye Biotechnology Holding source filings ↗